These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection]. Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738 [TBL] [Abstract][Full Text] [Related]
11. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database. Renoud L; Khouri C; Revol B; Lepelley M; Perez J; Roustit M; Cracowski JL JAMA Intern Med; 2021 Sep; 181(9):1243-1245. PubMed ID: 33904857 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis. Pegat A; Vogrig A; Khouri C; Masmoudi K; Vial T; Bernard E Ann Neurol; 2022 Jan; 91(1):162-163. PubMed ID: 34699065 [No Abstract] [Full Text] [Related]
13. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination. Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134 [TBL] [Abstract][Full Text] [Related]
14. Reply to 'Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis' by Dr Pegat et al. Maramattom BV Ann Neurol; 2022 Jan; 91(1):163. PubMed ID: 34704270 [No Abstract] [Full Text] [Related]
16. Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain-Barre syndrome following the first dose? Finsterer J Indian J Public Health; 2022; 66(3):385-386. PubMed ID: 36149133 [No Abstract] [Full Text] [Related]
17. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622 [TBL] [Abstract][Full Text] [Related]
18. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? Oo WM; Giri P; de Souza A J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365 [TBL] [Abstract][Full Text] [Related]
19. Before SARS-CoV-2 Vaccine is Held Responsible for Guillain-Barre Syndrome, Other Causes Must be Removed From the Table. Finsterer J J Clin Neuromuscul Dis; 2024 Mar; 25(3):146-148. PubMed ID: 38441933 [No Abstract] [Full Text] [Related]
20. Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients. Tayebi A; Samimisedeh P; Jafari Afshar E; Mahmoudnia S; Milan N; Ayati A; Madady A; Rastad H BMC Neurol; 2023 Dec; 23(1):437. PubMed ID: 38082244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]